http://www.fulcrumtx.com
Fulcrum Therapeutics, Inc. Company Intro
Modulating gene expression to treat the root cause of genetically defined diseases. Learn more about our pipeline and our culture.
Industry
Healthcare
Fulcrum Therapeutics, Inc. Headquaters
26 Landsdowne Street
Cambridge,02139
United States
Fulcrum Therapeutics, Inc. Share price
14 Sep 2022 09:17 GMT
$8.07
-0.31 (-3.7 %)
Fulcrum Therapeutics, Inc. Market cap
$355.207 M
WMC RANKING
2023
Fulcrum Therapeutics, Inc. # 211
BiotechnologyLatest Fulcrum Therapeutics, Inc. News
24 Mar 2023
Beta Thalassemia Market to Observe Impressive Growth ...
... Editas Medicine, Fulcrum Therapeutics, Allife Medical Science and Technology, Global Blood Therapeutics, Inc, Orchard Therapeutics, Acceleron Pharma,...
24 Mar 2023
12+ Active Companies working to Develop 12+ Pipeline ...
All news about FULCRUM THERAPEUTICS, INC. 1m ago. 12+ Active Companies working to Develop 12+ Pipeline Therapies for... 03/13.
24 Mar 2023
Beta Thalassemia Market to Observe Impressive Growth ...
... Editas Medicine, Fulcrum Therapeutics, Allife Medical Science and Technology, Global Blood Therapeutics, Inc, Orchard Therapeutics, Acceleron Pharma,...
WMC Market Score
WMC Market to Revenue Score
Fulcrum Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Fulcrum Therapeutics, Inc. | USD | $12,862 | $82,720 | $-69,366 | $3,552M | 211 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Fulcrum Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Fulcrum Therapeutics, Inc. Post vs Top 4 Industry Competitors
Fulcrum Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Fulcrum Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Fulcrum Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Fulcrum Therapeutics, Inc. | 0.14 | 3.13 | 100 | 0 | 0 | 0 | 47.50 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 15.39 | 22 | 0 | 0 | 28.79 |
| Vertex Pharmaceuticals Incorporated | 0 | 0 | 0 | 33 | 0 | 0 | 14.97 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 95.30 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.03 | 100 | 0 | 0 | 48.40 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
